Skip to main content
. 2016 Mar 11;2016(3):CD005563. doi: 10.1002/14651858.CD005563.pub3

Comparison 3. Prophylactic antipsychotic versus control.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Incident delirium 3 916 Risk Ratio (M‐H, Random, 95% CI) 0.73 [0.33, 1.59]
1.1 Haloperidol 2 516 Risk Ratio (M‐H, Random, 95% CI) 1.05 [0.69, 1.60]
1.2 Olanzapine 1 400 Risk Ratio (M‐H, Random, 95% CI) 0.36 [0.24, 0.52]
2 Duration of delirium 2 178 Mean Difference (IV, Random, 95% CI) ‐2.74 [‐9.59, 4.11]
2.1 Haloperidol 1 68 Mean Difference (IV, Random, 95% CI) ‐6.4 [‐9.38, ‐3.42]
2.2 Olanzapine 1 110 Mean Difference (IV, Random, 95% CI) 0.60 [0.10, 1.10]
3 Severity of delirium 2 178 Mean Difference (IV, Random, 95% CI) ‐1.02 [‐6.80, 4.76]
3.1 Haloperidol 1 68 Mean Difference (IV, Random, 95% CI) ‐2.00 [‐5.86, ‐2.14]
3.2 Olanzapine 1 110 Mean Difference (IV, Random, 95% CI) 1.90 [0.41, 3.39]
4 Length of admission 1 68 Mean Difference (IV, Random, 95% CI) ‐5.5 [‐12.17, 1.17]
4.1 Haloperidol 1 68 Mean Difference (IV, Random, 95% CI) ‐5.5 [‐12.17, 1.17]
5 Cognition 1 110 Mean Difference (IV, Random, 95% CI) ‐4.90 [‐7.42, ‐2.38]
6 Withdrawal from protocol 2 925 Risk Ratio (M‐H, Random, 95% CI) 0.92 [0.68, 1.24]
6.1 Haloperidol 1 430 Risk Ratio (M‐H, Random, 95% CI) 0.73 [0.43, 1.26]
6.2 Olanzapine 1 495 Risk Ratio (M‐H, Random, 95% CI) 1.02 [0.71, 1.46]
7 Adverse events 1 430 Risk Ratio (M‐H, Random, 95% CI) 0.39 [0.10, 1.43]
7.1 Haloperidol 1 430 Risk Ratio (M‐H, Random, 95% CI) 0.39 [0.10, 1.43]
8 Pneumonia 1 400 Risk Ratio (M‐H, Random, 95% CI) 7.28 [0.38, 140.11]
9 Urinary tract infection 1 400 Risk Ratio (M‐H, Random, 95% CI) 0.26 [0.03, 2.31]
10 Congestive heart failure 1 400 Risk Ratio (M‐H, Random, 95% CI) 1.04 [0.07, 16.52]